Company attributes
B2X
0
AngelList URL
Pitchbook URL
Legal Name
Merrimack Pharmaceuticals, Inc.
Number of Employees (Ranges)
51 – 2000
Email Address
info@merrimack.com0
Phone Number
+161772086060
Full Address
One Kendall Square, Cambridge, Massachusetts 02139, US
One Broadway, 14th floor Cambridge, MA 021420
CIK Number
Place of Incorporation
Investors
DUNS Number
0012214100
Founded Date
2000
Total Funding Amount (USD)
77,000,000
Latest Funding Round Date
April 14, 2011
Stock Symbol
MACK0
Exchange
Latest Funding Type
NAICS Code
325,4120
CAGE Code
6ZU980
Patents Assigned (Count)
49
Wellfound ID
Headquarters
Other attributes
Company Operating Status
Active
SIC Code
2,8340
Ticker Symbol
MACK
Wikidata ID
Merrimack Pharmaceuticals is a biopharmaceutical company that is entitled to receive contingent milestone payments related to its sale of ONIVYDE® to Ipsen S.A. (“Ipsen”) in April 2017. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets.
The Company does not have any employees and instead uses external consultants for the operation of the Company.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
